Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 36Active not recruiting 22Not yet recruiting 6Terminated 5Suspended 2Completed 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1Dermatologic 1

Conditions

Neoplasms 1Melanoma 1Carcinoma, Renal Cell 1

Interventions

Specimen Handling 25Magnetic Resonance Spectroscopy 17Biopsy 15Cyclophosphamide 6venetoclax 5Vincristine 4Surgical Procedures, Operative 4Radiotherapy, Intensity-Modulated 4Nivolumab 4Etoposide 4Azacitidine 4pembrolizumab 3fludarabine phosphate 3X-Rays 3Taxes 3Radiation 3Injections 3Cetuximab 3trastuzumab deruxtecan 2fludarabine 2decitabine and cedazuridine drug combination 2cemiplimab 2Tacrolimus 2Standard of Care 2Sirolimus 2Radiotherapy 2Radiosurgery 2Prednisone 2Practice Guidelines as Topic 2Paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Practice Guidelines as Topic × 90 days × Clear all
NCT06391099 2026-05-26

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
60 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT03568292 2026-05-13

Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures

University of Southern California

Phase NA Suspended
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡